| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 139.2 | 149.2 | 104.2 |
| Other income | 7.4 | 2.5 | 6.4 |
| Total income | 146.6 | 151.7 | 110.5 |
| Profit before exceptional items & tax | 24.5 | 17.8 | 11.8 |
| Profit before tax | 24.5 | 17.8 | 11.8 |
| Net profit | 18.4 | 13.5 | 9.2 |
| Operating margin | 16.7% | 11.7% | 10.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +100.00% |
|---|---|
| Net profit, quarter on quarter | +36.30% |
| Revenue, year on year | +33.60% |
| Operating profit, year on year | +216.70% |
| Operating profit, quarter on quarter | +11.80% |
BSE results filing, NSE: NGLFINE. Figures extracted from the filing.
NGL Fine - Chem Ltd: key numbers
- Share price
- ₹2,906.10
- Market cap
- ₹1,795 Cr
- Revenue (annual)
- ₹500.9 Cr
- Net profit (annual)
- ₹48.13 Cr
- P/E (TTM)
- 31.4×Sector 50.4×
- Promoter holding
- 72.49%-0.25% QoQ
- FII holding
- 0.05%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from NGL Fine - Chem Ltd
All →NGL Fine - Chem Legal & Regulatory
NGL Fine Chem received a GST Show Cause Notice for FY 2022-23 with a total demand of ₹6.19 Crore. The company intends to contest the notice.
- Value
- ₹6.19 Cr
- From
- Office of the Deputy Commissioner of State Tax
NGL Fine - Chem Production Started
NGL Fine-Chem Limited has commenced commercial production at Phase II of its Greenfield facility in Tarapur. The total investment for the expansion facility is approximately ₹222 Crore.
- Value
- ₹222.0 Cr
NGL Fine - Chem Investor Presentation: Key Takeaways
NGL Fine-Chem reported robust Q1FY27 performance with Revenue of ₹139.16 Cr (up 33.6% YoY) and PAT of ₹18.40 Cr (up 99.1% YoY). Growth was driven by sustained demand and forex gains.
NGL Fine - Chem Earnings Call: Key Takeaways
NGL Fine-Chem reported strong Q4 FY26 results with 57% YoY revenue growth and significant margin expansion. Management focuses on capacity expansion and penetrating regulated markets (Europe/US).
NGL Fine - Chem Earnings Call: Key Takeaways
NGL Fine Chem reports a strong recovery in FY26, driven by higher volumes and expanded intermediate production. However, management remains cautious about returning to peak historical margins due to persistent global competition and cost pressures.
NGL Fine - Chem Earnings Call: Key Takeaways
NGL Fine-Chem delivered strong FY26 performance with revenue up 36% to ₹501cr and PAT up 127% to ₹48cr, driven by volume growth in the animal health segment.